A Novel Detection of Using Multiple Cross Displacement Amplification Linked with Gold Nanoparticle Lateral Flow Biosensor
Overview
Affiliations
Background: , an opportunistic bacterial pathogen, is one of the most frequently isolated bacterial species and cause of serious nosocomial infections in recent decades. A reliable and rapid assay for detection is significant for the diagnosis and follow-up treatment.
Methods: A novel assay method, named multiple cross displacement amplification linked with nanoparticle-based lateral flow biosensor (MCDA-LFB), was applied for detecting strains. A set of special 10 primers was designed according to -specific gene . The MCDA amplification conditions, including the target DNA concentration, reaction temperature and time, were optimized. The sensitivity and specificity of MCDA method were tested in the current study, and then, the MCDA-LFB technology was applied to detect the strain from clinical samples.
Results: The specific primers were valid for the establishment of MCDA-LFB technology forthe detection of based on the gene. The MCDA amplification condition was optimized at 62°C for 35 min. The MCDA products were directly sensed and displayed with a biosensor. The full process, comprising genomic DNA template preparation (approximately 30 mins), amplification of MCDA (35 mins), and the product identification (approximately 2 mins), could be achieved in 70 mins. The MCDA technique could detect as little as 10 fg per reaction system of pure genomic DNA. The specificity of MCDA-LFB method is 100%, with no cross-reactions to non- strains.
Conclusion: The MCDA-LFB technique established in the present study is a reliable, simple, rapid, sensitive and specific method to assay and can be applied for the detection of clinical samples.
Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases.
Hung Y, Chen Y, Tsai P, Huang I, Ko W, Jan J Pharmaceutics. 2021; 13(11).
PMID: 34834328 PMC: 8618949. DOI: 10.3390/pharmaceutics13111913.
Yang X, Huang J, Chen X, Xiao Z, Wang X, Chen Y Front Microbiol. 2021; 12:708658.
PMID: 34408738 PMC: 8365424. DOI: 10.3389/fmicb.2021.708658.
Chen X, Huang J, Xiao Z, Yang X, Chen Y, Zheng W Braz J Microbiol. 2021; 52(3):1315-1325.
PMID: 34176103 PMC: 8324766. DOI: 10.1007/s42770-021-00520-4.
Chen X, Zhou Q, Dong S, Wang S, Liu R, Wu X Infect Drug Resist. 2021; 14:1219-1229.
PMID: 33790592 PMC: 8007573. DOI: 10.2147/IDR.S297645.